These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pharmacogenetics for genes associated with age-related macular degeneration in the Comparison of AMD Treatments Trials (CATT). Hagstrom SA, Ying GS, Pauer GJT, Sturgill-Short GM, Huang J, Callanan DG, Kim IK, Klein ML, Maguire MG, Martin DF, Comparison of AMD Treatments Trials Research Group. Ophthalmology; 2013 Mar; 120(3):593-599. PubMed ID: 23337555 [Abstract] [Full Text] [Related]
3. Growth of geographic atrophy in the comparison of age-related macular degeneration treatments trials. Grunwald JE, Pistilli M, Ying GS, Maguire MG, Daniel E, Martin DF, Comparison of Age-related Macular Degeneration Treatments Trials Research Group. Ophthalmology; 2015 Apr; 122(4):809-16. PubMed ID: 25542520 [Abstract] [Full Text] [Related]
6. Single-Nucleotide Polymorphisms Associated With Age-Related Macular Degeneration and Lesion Phenotypes in the Comparison of Age-Related Macular Degeneration Treatments Trials. Maguire MG, Ying GS, Jaffe GJ, Toth CA, Daniel E, Grunwald J, Martin DF, Hagstrom SA, CATT Research Group. JAMA Ophthalmol; 2016 Jun 01; 134(6):674-81. PubMed ID: 27099955 [Abstract] [Full Text] [Related]
12. Association of Single-Nucleotide Polymorphisms in Age-Related Macular Degeneration With Pseudodrusen: Secondary Analysis of Data From the Comparison of AMD Treatments Trials. Lin LY, Zhou Q, Hagstrom S, Maguire MG, Daniel E, Grunwald JE, Martin DF, Ying GS, CATT Research Group. JAMA Ophthalmol; 2018 Jun 01; 136(6):682-688. PubMed ID: 29801032 [Abstract] [Full Text] [Related]
14. Risk of geographic atrophy in the comparison of age-related macular degeneration treatments trials. Grunwald JE, Daniel E, Huang J, Ying GS, Maguire MG, Toth CA, Jaffe GJ, Fine SL, Blodi B, Klein ML, Martin AA, Hagstrom SA, Martin DF, CATT Research Group. Ophthalmology; 2014 Jan 01; 121(1):150-161. PubMed ID: 24084496 [Abstract] [Full Text] [Related]
16. Genetic analysis of simultaneous geographic atrophy and choroidal neovascularization. Grob S, Luo J, Hughes G, Lee C, Zhou X, Lee J, Du H, Ferreyra H, Freeman WR, Kozak I, Zhang K. Eye (Lond); 2012 Aug 01; 26(8):1106-13. PubMed ID: 22699975 [Abstract] [Full Text] [Related]
18. Association of complement factor H and LOC387715 genotypes with response of exudative age-related macular degeneration to intravitreal bevacizumab. Brantley MA, Fang AM, King JM, Tewari A, Kymes SM, Shiels A. Ophthalmology; 2007 Dec 01; 114(12):2168-73. PubMed ID: 18054635 [Abstract] [Full Text] [Related]
20. Incidence and Growth of Geographic Atrophy during 5 Years of Comparison of Age-Related Macular Degeneration Treatments Trials. Grunwald JE, Pistilli M, Daniel E, Ying GS, Pan W, Jaffe GJ, Toth CA, Hagstrom SA, Maguire MG, Martin DF, Comparison of Age-Related Macular Degeneration Treatments Trials Research Group. Ophthalmology; 2017 Jan 01; 124(1):97-104. PubMed ID: 28079023 [Abstract] [Full Text] [Related] Page: [Next] [New Search]